Log in to save to my catalogue

Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sust...

Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sust...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ed70a04355a4fed8481dd542b4ecb2b

Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling

About this item

Full title

Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling

Publisher

Switzerland: MDPI AG

Journal title

Cells (Basel, Switzerland), 2022-11, Vol.11 (22), p.3632

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Castration-resistant prostate cancer (CRPC) remains an incurable and lethal malignancy. The development of new CRPC treatment strategies is strongly impeded by the scarcity of representative, scalable and transferable preclinical models of advanced, androgen receptor (AR)-driven CRPC. Here, we present contemporary patient-derived xenografts (PDXs)...

Alternative Titles

Full title

Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9ed70a04355a4fed8481dd542b4ecb2b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ed70a04355a4fed8481dd542b4ecb2b

Other Identifiers

ISSN

2073-4409

E-ISSN

2073-4409

DOI

10.3390/cells11223632

How to access this item